Sign Out
Pregnancy: Bisoprolol (Concore) is not recommended during pregnancy unless clearly necessary. If treatment is considered necessary, monitoring of the uteroplacental blood flow and the fetal growth is recommended. In case of harmful effects on pregnancy or the fetus, consideration of alternative treatment is recommended. The newborn infant must be closely monitored. Symptoms of hypoglycemia and bradycardia are generally to be expected within the first 3 days.
Lactation: There are no data on the excretion of bisoprolol (Concore) in human breast milk or the safety of bisoprolol (Concore) exposure in infants. Therefore, breastfeeding is not recommended during administration of bisoprolol (Concore).
